To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Freenome, Inc. by 36,654 shares, the number of shares held decreased 4.78% compared to the previous period and now represents 0.55% of the total position.
      49Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Prime Medicine, Inc. by 381,710 shares, the number of shares held decreased 4.78% compared to the previous period and now represents 1.15% of the total position.
      95Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Generate Biomedicines by 77,613 shares, the number of shares held decreased 4.78% compared to the previous period and now represents 1.23% of the total position.
      58Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Alamar Biosciences by 48,626 shares, the number of shares held decreased 4.78% compared to the previous period and now represents 1.5% of the total position.
      1Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Intellia Therapeutics by 130,257 shares, the number of shares held decreased 4.78% compared to the previous period and now represents 1.54% of the total position.
      9Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Illumina by 18,245 shares, the number of shares held decreased 4.78% compared to the previous period and now represents 4.48% of the total position.
      101Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Nurix Therapeutics by 85,444 shares, the number of shares held decreased 4.78% compared to the previous period and now represents 1.96% of the total position.
      69Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Veracyte by 30,219 shares, the number of shares held decreased 2.83% compared to the previous period and now represents 2.19% of the total position.
      27Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Ionis Pharmaceuticals by 43,050 shares, the number of shares held decreased 4.78% compared to the previous period and now represents 1.81% of the total position.
      76Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 692,900 shares, the number of shares held decreased 4.78% compared to the previous period and now represents 2.46% of the total position.
      228Comment
      Report
       
       
       
       

      Most Discussed